ARS Pharmaceuticals, Inc. — 8-K Filings
60 8-K filings on record
This page lists all 8-K filings submitted to the SEC by ARS Pharmaceuticals, Inc. (SPRY), sorted by most recent first. Each row links to the full filing on EdgarLookup. ARS Pharmaceuticals, Inc. has filed 60 8-K documents with the SEC since 2016. To view all SEC filings by ARS Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
PREM14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-097467 | Mar 9, 2026 | — |
| 8-K | 8-K | 0001193125-25-273107 | Nov 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-223228 | Sep 29, 2025 | — |
| 8-K | 8-K | 0001193125-25-190202 | Aug 28, 2025 | Aug 13, 2025 |
| 8-K | 8-K | 0000950170-25-107617 | Aug 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-148922 | Jun 26, 2025 | Jun 25, 2025 |
| 8-K | 8-K | 0000950170-25-070899 | May 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-110696 | May 2, 2025 | — |
| 8-K | 8-K | 0000950170-25-042317 | Mar 20, 2025 | — |
| 8-K | 8-K | 0001193125-25-047351 | Mar 5, 2025 | — |
| 8-K | 8-K | 0001193125-25-005014 | Jan 13, 2025 | — |
| 8-K | 8-K | 0000950170-24-125921 | Nov 13, 2024 | — |
| 8-K | 8-K | 0001193125-24-255185 | Nov 12, 2024 | Nov 9, 2024 |
| 8-K | 8-K | 0001193125-24-237191 | Oct 15, 2024 | Oct 8, 2024 |
| 8-K | 8-K | 0001193125-24-223676 | Sep 23, 2024 | Sep 17, 2024 |
| 8-K | 8-K | 0001193125-24-198384 | Aug 12, 2024 | Aug 9, 2024 |
| 8-K | 8-K | 0000950170-24-091745 | Aug 6, 2024 | — |
| 8-K | 8-K | 0001193125-24-172166 | Jun 28, 2024 | — |
| 8-K | 8-K | 0001193125-24-171204 | Jun 28, 2024 | Jun 27, 2024 |
| 8-K | 8-K | 0001193125-24-165812 | Jun 21, 2024 | Jun 20, 2024 |
| 8-K | 8-K | 0001193125-24-135721 | May 10, 2024 | — |
| 8-K | 8-K | 0000950170-24-056934 | May 9, 2024 | — |
| 8-K | 8-K | 0000950170-24-034678 | Mar 21, 2024 | — |
| 8-K | 8-K | 0001193125-24-061842 | Mar 7, 2024 | — |
| 8-K | 8-K | 0000950170-23-061989 | Nov 9, 2023 | — |
| 8-K | 8-K | 0001193125-23-241345 | Sep 25, 2023 | — |
| 8-K | 8-K | 0001193125-23-237996 | Sep 20, 2023 | Sep 19, 2023 |
| 8-K | 8-K | 0000950170-23-041294 | Aug 10, 2023 | — |
| 8-K | 8-K | 0001193125-23-177543 | Jun 28, 2023 | Jun 27, 2023 |
| 8-K | 8-K | 0001193125-23-146147 | May 16, 2023 | — |
| 8-K | 8-K | 0000950170-23-021996 | May 15, 2023 | — |
| 8-K | 8-K | 0001193125-23-139053 | May 9, 2023 | — |
| 8-K | 8-K | 0000950170-23-009485 | Mar 23, 2023 | — |
| 8-K | 8-K | 0001193125-23-068584 | Mar 13, 2023 | — |
| 8-K | 8-K | 0001193125-23-044823 | Feb 22, 2023 | — |
| 8-K | 8-K | 0001193125-23-036914 | Feb 14, 2023 | — |
| 8-K | 8-K | 0001193125-22-301873 | Dec 9, 2022 | Dec 6, 2022 |
| 8-K | 8-K | 0001193125-22-299482 | Dec 6, 2022 | — |
| 8-K | 8-K | 0001193125-22-280241 | Nov 8, 2022 | Nov 4, 2022 |
| 8-K | 8-K | 0001193125-22-275336 | Nov 2, 2022 | Nov 1, 2022 |
| 8-K | 8-K | 0001193125-22-270962 | Oct 27, 2022 | Oct 25, 2022 |
| 8-K | 8-K | 0001193125-22-266351 | Oct 21, 2022 | — |
| 8-K | 8-K | 0001193125-22-255494 | Sep 30, 2022 | Sep 27, 2022 |
| 8-K | 8-K | 0001193125-22-237900 | Sep 2, 2022 | Sep 1, 2022 |
| 8-K | 8-K | 0001193125-22-199246 | Jul 21, 2022 | — |
| 8-K | 8-K | 0001193125-22-172958 | Jun 13, 2022 | Jun 10, 2022 |
| 8-K | 8-K | 0001193125-22-148646 | May 12, 2022 | — |
| 8-K | 8-K | 0001193125-22-143631 | May 6, 2022 | May 2, 2022 |
| 8-K | 8-K | 0001193125-22-091747 | Mar 31, 2022 | — |
| 8-K | 8-K | 0001193125-22-078295 | Mar 17, 2022 | Mar 11, 2022 |